Statins associated with reduced morbidity and mortality in patients with primary sclerosing cholangitischolangi
(European Association for the Study of the Liver) An award-winning register-based study reports a reduced risk of all-cause mortality, liver transplantation, liver cancer, and variceal bleeding in patients with primary sclerosing cholangitis exposed to statins.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Bleeding | Cancer | Cancer & Oncology | Cholesterol | International Medicine & Public Health | Liver | Liver Transplant | Statin Therapy | Study | Transplants | Urology & Nephrology